Evidence map›Paper›PMID 26657454›Full record

ArticleEuropean journal of gastroenterology & hepatology2016

Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis.

Yoshio Aizawa, Hiroshi Abe, Tomonori Sugita, Nobuyoshi Seki, Yoshimichi Chuganji, Youhei Furumoto, Akihiko Sakata

Open access · hybridAbstract readComparative StudyMulticenter Study
In one paragraph

Article in European journal of gastroenterology & hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2018
    Article
  10. Review
  11. Article
  12. Autoimmune hepatitis: current challenges and future prospects.Clinical and experimental gastroenterology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yoshio AizawaDepartments of aGastroenterology and Hepatology bPathology, The Jikei University Katsushika Medical Center cDepartment of Internal Medicine, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.
Hiroshi Abe
Tomonori Sugita
Nobuyoshi Seki
Yoshimichi Chuganji
Youhei Furumoto
Akihiko Sakata
Katsushika Medical Center · JPCreative Commons · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimCentrilobular zonal necrosis (CZN) is a known histological variant of autoimmune hepatitis (AIH). However, the significance of CZN is yet to be fully elucidated. This study aimed to determine whether CZN is a hallmark of a distinctive subtype of AIH.

methodsHistological changes in the centrilobular zones of liver biopsies from 113 AIH patients were assessed by a single pathologist and classified into three categories: typical zonal necrosis defined as CZN (15 patients); other necroinflammatory change (NIC; 24 patients); and absence of necrosis (non-NIC; 74 patients). The clinicopathological features and immunogenetic background of CZN patients were then assessed.

resultsThe clinicopathological features of AIH with CZN were distinct from other types of AIH, including a higher frequency of acute onset, lower frequency of antinuclear antibodies, lower antinuclear antibody titers, lower serum immunoglobulin G levels, lower grade interface hepatitis, less prominent lymphoplasmacytic infiltration, and lower AIH score. Increased and decreased frequencies of HLA-DR9 and HLA-DR4, respectively, were identified as immunogenetic features of AIH with CZN. Conversely, the clinicopathological characteristics of AIH with NIC were similar to those of non-NIC AIH, including the majority of the AIH patients. The therapeutic outcomes of AIH with CZN were excellent when precise diagnoses were made without delay.

conclusionThe clinicopathological features and immunogenetic background of AIH with CZN differed from AIH without CZN. CZN may be a hallmark of a distinct subtype of AIH.

Indexed as

AgedAutoantibodiesBiomarkersBiopsyCase-Control StudiesFemaleHepatitis, AutoimmuneHLA-DR AntigensHumansImmunoglobulin MImmunosuppressive AgentsJapanLiverLiver CirrhosisMaleMiddle AgedAutoantibodiesBiomarkersHLA-DR AntigensImmunoglobulin MImmunosuppressive Agents

Identifiers

PMID26657454
PMCPMC4777223
OpenAlexW2316955311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.